Status:
COMPLETED
Creatine Supplementation and Diabetes
Lead Sponsor:
University of Sao Paulo
Conditions:
Diabetes
Renal Function
Eligibility:
All Genders
45+ years
Phase:
NA
Brief Summary
Creatine supplementation is capable of improving glucose tolerance in healthy subjects. The researchers aim to investigate whether this supplement can affect metabolic control in diabetic patients.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- males and females type 2 diabetic patients
- glycated hemoglobin between \> 9%
- non insulin users
- physically inactive
- only metformin and/or sulfonylurea users
- BMI \> 30 kg/m2
- age of years \> 50 y
Exclusion
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT00992043
Start Date
October 1 2009
End Date
January 1 2010
Last Update
March 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital - School of Medicine - University of Sao Paulo
São Paulo, São Paulo, Brazil, 05508-030